We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$3.09T
AUM Growth
+$3.09T
(+123,949%)
Cap. Flow
-$2.6B
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
58.75%
Holding
380
New
–
Increased
–
Reduced
–
Closed
54
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$226M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$196M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$159M |
| 4 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$157M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.61% |
| 2 | Consumer Discretionary | 4.59% |
| 3 | Technology | 4.59% |
| 4 | Communication Services | 4.45% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
AbbVie
ABBV
$450B
| – | – |
0
| – | – |
|
77
Morgan Stanley
MS
$339B
| – | – |
0
| – | – |
|
78
Merck
MRK
$315B
| – | – |
0
| – | – |
|
79
Nike
NKE
$64.9B
| – | – |
0
| – | – |
|
80
Goldman Sachs
GS
$314B
| – | – |
0
| – | – |
|
81
Thermo Fisher Scientific
TMO
$198B
| – | – |
0
| – | – |
|
82
Intel
INTC
$478B
| – | – |
0
| – | – |
|
83
Cisco
CSCO
$441B
| – | – |
0
| – | – |
|
84
Broadcom
AVGO
$1.76T
| – | – |
0
| – | – |
|
85
McDonald's
MCD
$190B
| – | – |
0
| – | – |
|
86
Eli Lilly
LLY
$1.05T
| – | – |
0
| – | – |
|
87
Danaher
DHR
$144B
| – | – |
0
| – | – |
|
|
SCHW
88
Charles Schwab
SCHW
$177B
| – | – |
0
| – | – |
|
89
S&P Global
SPGI
$133B
| – | – |
0
| – | – |
|
90
Amgen
AMGN
$198B
| – | – |
0
| – | – |
|
91
Bristol-Myers Squibb
BMY
$124B
| – | – |
0
| – | – |
|
92
Accenture
ACN
$87.9B
| – | – |
0
| – | – |
|
93
Lowe's Companies
LOW
$117B
| – | – |
0
| – | – |
|
94
Texas Instruments
TXN
$258B
| – | – |
0
| – | – |
|
95
Starbucks
SBUX
$120B
| – | – |
0
| – | – |
|
96
Intuit
INTU
$79.6B
| – | – |
0
| – | – |
|
97
ConocoPhillips
COP
$140B
| – | – |
0
| – | – |
|
98
Target
TGT
$63.4B
| – | – |
0
| – | – |
|
99
Oracle
ORCL
$364B
| – | – |
0
| – | – |
|
100
Intuitive Surgical
ISRG
$122B
| – | – |
0
| – | – |
|
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, WestEnd Advisors held 380 positions worth $3.09T, up 123,949% from $2.49B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
WestEnd Advisors's Q2 2021 filing shows 54 closed positions. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $226M.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Technology.
- WestEnd Advisors fully exited Vanguard FTSE All-World ex-US ETF in Q2 2021, selling an estimated $226M.
- WestEnd Advisors's ten largest holdings make up 59% of its $3.09T portfolio in Q2 2021.
- WestEnd Advisors opened 0 new positions and closed 54 in Q2 2021.
- WestEnd Advisors's portfolio value rose 123,949% quarter-over-quarter to $3.09T.
Based on WestEnd Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.